SUSQUEHANNA INTERNATIONAL GROUP, LLP - TRANSCEPT PHARMACEUTICALS IN ownership

TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 40 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$89,000
-69.5%
44,192
-69.8%
0.00%
Q2 2014$292,000
-40.5%
146,532
-8.2%
0.00%
Q1 2014$491,000
-8.6%
159,564
-0.2%
0.00%
Q4 2013$537,000
+154.5%
159,921
+140.5%
0.00%
Q3 2013$211,000
-46.9%
66,502
-49.3%
0.00%
Q2 2013$397,000131,1730.00%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q4 2013
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,031,874$6,258,0006.29%
NEA Management Company, LLC 2,086,755$6,427,0000.32%
BVF INC/IL 150,000$462,0000.07%
Central Square Management LLC 19,000$59,0000.06%
ABNER HERRMAN & BROCK LLC 20,000$62,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 137,000$422,0000.01%
SHEPHERD KAPLAN KROCHUK, LLC 31,000$95,0000.01%
Spark Investment Management LLC 11,100$34,0000.01%
Waverly Advisors, LLC 2,670$8,0000.00%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 33,384$103,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders